ASTRO 2020 – Virtual

25-28 October 2020

Miami, USA

“Artificial Intelligence powered solutions should become part of the new era of cancer treatment in all centers. We look forward to working with you and implementing our solutions in your daily routine for simpler and better clinical workflow and outcomes.

Professor Nikos Paragyios
CEO & CTO at TheraPanaceaProfessor of Mathematics – University of Paris-Saclay
Editor in Chief, Computer Vision at Elsevier

Product Launch

ART-Plan™ brings AI into radiotherapy

AI: a hidden link between ART and Radiotherapy? Join us and discover our exclusive multidisciplinary exhibition for ASTRO 2020.

Watch our product launch

Webinar

Watch the replay

TheraPanacea at ASTRO 2020:

Scientific oral and poster presentations

TheraPanacea on the frontier: Explore our scientific oral and poster presentatios at ASTRO 2020.

Improving radiotherapy workflow through implementation of delineation guidelines & AI-based annotation

M. Ung1, A. Rouyar-Nicolas1,2, E. Limkin1, C. Petit1, T. Sarrade1, A. Carre1,2, G. Auzac1, A. Lombard3, E. Ullman3, N. Bonnet4, L. G. Assia4, N. Paragios3, C. Huynh3, E. Deutsch1,2, S. Rivera1,2, and C. Robert1,2

1Gustave Roussy, Cancer Campus, Villejuif, France,
2Molecular radiotherapy and innovative therapeutics, INSERM UMR1030, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.
3Therapanacea, Paris, France,

(2708 – 25th Oct 2:15PM – special session – Session 2)

SIMSEB: Unlocking the Dosimetric Potential of Sequential Boost Plans in VMAT Through Simultaneous Optimization

Rutger H.J. Fick1, Thierry Boulé1, Antoine Pouille1, Aurelien Lombard1, Norbert Bus1 and Nikos Paragios1

1Therapanacea, Paris, France

(2861 – 25th Oct 2:15PM – Special Session – Session 2)

A blinded prospective evaluation of clinical applicability of deep learning-based auto contouring of OAR for Head & Neck radiotherapy

P Blanchard1, V Grégoire2, C Petit1, N Milhade2, A Allajbej2, F Nguyen1, S Bakkar1, G Boulle1, E Romano1, W Zrafi1, A Lombard3, G Beldjoudi2, A Munoz2, E Ullmann3, N Paragios3, E Deutsch1,4, C Robert1,4.

1Gustave Roussy Cancer Campus, Villejuif, France;
2Léon Bérard Cancer Center, Lyon, France;
3Therapanacea, Paris, France;
4Molecular radiotherapy and innovative therapeutics, INSERM UMR1030, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France

(3815 – 28th Oct 2PM – special session – Session 7)